缺血性卒中幸存者的苯二氮䓬类药物使用:分析初始过量供应与纵向趋势
该研究分析2013年4月1日至2021年9月30日美国联邦医疗保险(Medicare)20%抽样数据,纳入126 050例年龄≥65岁、急性缺血性卒中后存活出院的受益人。出院后90天内4.9%启动苯二氮䓬类药物,多数首次处方日供应量超过7天(76%),女性启动率高于男性(5.5% vs 3.8%),东南部最高(5.1%)、中西部最低(4.0%),2013至2021年全国启动率小幅下降(累积发生率差1.6%)。
要点
- 出院后90天内4.9%的缺血性卒中幸存者启动苯二氮䓬类药物。
- 首次处方中76%日供应量超过7天,55%为15至30天。
- 女性启动率5.5%高于男性3.8%,东南部5.1%最高、中西部4.0%最低。
核心结论
- 尽管2013至2021年苯二氮䓬类药物启动率逐渐下降,但急性缺血性卒中出院后处方仍存在过量供应,作者强调需要改进政策。
研究设计与样本
- 研究分析了2013年4月1日至2021年9月30日美国联邦医疗保险(Medicare)20%抽样索赔数据。
- 纳入年龄≥65岁、急性缺血性卒中后存活出院、具有传统Medicare覆盖且此前6个月参加A部分(住院保险)、B部分(医疗保险)和D部分(药物覆盖)的受益人。
- 排除既往有苯二氮䓬类药物处方、自行出院或出院至专业护理机构者,最终纳入126 050例受益人,平均年龄78岁(SD,8),54%为女性,82%为白人。
主要发现
- 出院后90天内,6127例(4.9%)启动苯二氮䓬类药物。
- 新处方中,劳拉西泮(40%)和阿普唑仑(33%)最常被处方。
- 首次处方中76%的日供应量超过7天,55%在15至30天之间。
- 女性启动率为5.5%(95% CI,5.3-5.7),男性为3.8%(95% CI,3.6%-3.9%)。
- 启动率东南部最高为5.1%(95% CI,4.8%-5.3%),中西部最低为4.0%(95% CI,3.8%-4.3%),2013至2021年全国启动率小幅下降(累积发生率差,1.6%)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Benzodiazepines are commonly prescribed for post-acute ischemic stroke for anxiety, insomnia, and agitation. While guidelines discourage use in those aged ≥65 years, little is known about prescription patterns at the national level. METHODS: We analyzed a 20% sample of US Medicare claims from April 1, 2013, to September 30, 2021. We selected beneficiaries aged ≥65 years discharged alive following an acute ischemic stroke who had traditional Medicare coverage and 6 months' prior enrollment in Parts A (hospital insurance), B (Medical insurance), and D (drug coverage). We excluded those with prior benzodiazepine prescriptions, self-discharges, or discharge to skilled nursing facilities. We examined demographics, comorbidities, first prescription days' supply, cumulative incidences of benzodiazepine first prescription fills within 90 days after discharge, and geographic and yearly trends. RESULTS: We included 126 050 beneficiaries with a mean age of 78 years (SD, 8); 54% were female and 82% were White. Within 90 days, 6127 (4.9%) initiated a benzodiazepine. Among new prescriptions, lorazepam (40%) and alprazolam (33%) were the most prescribed. Most (76%) of first fills had a day's supply over 7 days and 55% between 15 and 30 days. Female initiation rates were higher (5.5% [95% CI, 5.3-5.7]) than male initiation rates (3.8% [95% CI, 3.6%-3.9%]). Rates were highest in the southeast (5.1% [95% CI, 4.8%-5.3%]) and lowest in the midwest (4.0% [95% CI, 3.8%-4.3%]), with a modest nationwide initiation decline from 2013 to 2021 (cumulative incidence difference, 1.6%). CONCLUSIONS: Despite a gradual decline in benzodiazepine initiation from 2013 to 2021, we noted excessive supplies in prescriptions post-acute ischemic stroke discharge, underscoring the need for improved policies.
引用
- Lomachinsky Torres V, Brooks JD, Donahue MA, et al. Benzodiazepine Utilization in Ischemic Stroke Survivors: Analyzing Initial Excess Supply and Longitudinal Trends. Stroke. 2024. PMID: 39417222. doi:10.1161/STROKEAHA.124.047257
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。